Distinct tumor biology has previously been identified in ccRCC; particularly with less up regulation of HIF and VEGF pathways in black patients to suggest a lower response to VEGF targeted therapies among black patients with ccRCC. This evidence concerns the gene VEGFA and nonpapillary renal cell carcinoma.